16 May 2019 : Clinical Research
Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma
DOI: 10.12659/MSM.916648
Med Sci Monit 2019; 25:3624-3635
HTML version available soon